Researchers at Britain’s University of Westminster have developed a
means to test a cure for hepatitis C, a deadly liver disease that causes
350,000 deaths around the world each year.
Hepatitis C is caused by the hepatitis C virus HCV and, for the first
time, a drug that is believed to cure the disease is being tested on
humans. The drug, TT-034, was developed using gene therapy by an
Australian company, Benitec Biopharma.